(Q43625479)

25 November 2017

title

B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection (English)

1 reference

25 November 2017

Xicheng Wang

1

1 reference

25 November 2017

Zheng Zhang

2

1 reference

25 November 2017

Shuye Zhang

3

1 reference

25 November 2017

Junliang Fu

4

1 reference

25 November 2017

Jinxia Yao

5

1 reference

25 November 2017

Yanmei Jiao

6

1 reference

25 November 2017

Hao Wu

7

1 reference

25 November 2017

Fu-Sheng Wang

8

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

European Journal of Immunology

25 November 2017

published in

1 reference

25 November 2017

volume

38

1 reference

25 November 2017

issue

11

1 reference

25 November 2017

page(s)

3226-3236

1 reference

Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

Dendritic cells and the control of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Is hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Loss of blood CD11c(+) myeloid and CD11c(-) plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Persistent abnormalities in peripheral blood dendritic cells and monocytes from HIV-1-positive patients after 1 year of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Differential restoration of myeloid and plasmacytoid dendritic cells in HIV-1-infected children after treatment with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Variations in plasmacytoid dendritic cell (PDC) and myeloid dendritic cell (MDC) levels in HIV-infected subjects on and off antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Differential susceptibility to human immunodeficiency virus type 1 infection of myeloid and plasmacytoid dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Differential susceptibility of human thymic dendritic cell subsets to X4 and R5 HIV-1 infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Preferential infection of dendritic cells during human immunodeficiency virus type 1 infection of blood leukocytes.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Opposing roles of blood myeloid and plasmacytoid dendritic cells in HIV-1 infection of T cells: transmission facilitation versus replication inhibition

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Dendritic cells in innate immune responses against HIV.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

B7-H1 is up-regulated in HIV infection and is a novel surrogate marker of disease progression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

B7-H1 expression is upregulated in peripheral blood CD14+ monocytes of patients with chronic hepatitis B virus infection, which correlates with higher serum IL-10 levels

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Expression of PD-L1, a marker of disease status, is not reduced by HAART in aviraemic patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Expression of programmed-death receptor ligands 1 and 2 may contribute to the poor stimulatory potential of murine immature dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

T(H)1 cells control themselves by producing interleukin-10.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

IL-10, T cell exhaustion and viral persistence

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Interleukin-10 determines viral clearance or persistence in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Resolution of a chronic viral infection after interleukin-10 receptor blockade

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Low interleukin-10 production is associated with diabetes in HIV-infected patients undergoing antiviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Pathogenesis of HIV infection: what the virus spares is as important as what it destroys

1 reference

https://api.crossref.org/works/10.1002%2FEJI.200838285

7 January 2021

Identifiers

DOI

10.1002/EJI.200838285

1 reference

release_rlirh5wdfrew7jkt46agtdik5u

25 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rlirh5wdfrew7jkt46agtdik5u

24 November 2022

mapped directly with Wikidata item

1 reference